Clinical Scorecard: Evaluating the Modified Frailty Index-5 as a Predictor of Major Complications Following Video-Assisted Thoracoscopic Lung Resections

At a Glance

Key Highlights

• MFI-5 is a simplified frailty index using five parameters: hypertension requiring medication, diabetes mellitus, COPD, congestive heart failure, and functional dependence.
• Each MFI-5 component is linked to increased risk of postoperative complications such as pneumonia, bronchopleural fistula, acute renal failure, and mortality.
• MFI-5 has demonstrated predictive value for major postoperative complications and 30-day mortality in patients undergoing VATS pulmonary resections.

Guideline-Based Recommendations

Diagnosis

• Assess MFI-5 parameters preoperatively: confirm hypertension requiring antihypertensive medication, diabetes mellitus status via HbA1c and endocrinologist input, COPD diagnosis by history and pulmonary function tests, CHF by echocardiography or cardiology evaluation, and functional independence status by evaluating ability to perform daily activities.

Management

• Consider MFI-5 score in preoperative risk stratification to identify patients at higher risk for major complications.
• Optimize control of hypertension and diabetes mellitus prior to surgery to reduce postoperative risks.
• Address pulmonary function and cardiac status preoperatively in patients with COPD and CHF.
• Plan perioperative care with heightened vigilance for patients with dependent functional status.

Monitoring & Follow-up

• Monitor for major complications including pneumonia requiring mechanical ventilation, empyema, atrial fibrillation, bronchopleural fistula, bleeding, acute renal failure, chylothorax, prolonged air leak, and 30- to 90-day postoperative mortality.
• Use Clavien–Dindo classification grade 2 or higher to define major complications.

Risks

• Patients with positive MFI-5 parameters have increased risk of fatal postoperative complications such as acute renal failure, acute coronary syndrome, stroke, respiratory failure, and infections.
• Sudden intraoperative hypotension related to antihypertensive medications may contribute to adverse events.

Patient & Prescribing Data

Patients undergoing VATS lobectomy or segmentectomy for NSCLC

Use of antihypertensive medications, especially ACE inhibitors or ARBs, is associated with increased risk of fatal postoperative complications due to intraoperative hypotension; glycemic control is critical to reduce infection and wound healing complications.

Clinical Best Practices

• Incorporate MFI-5 assessment into preoperative evaluation for lung resection candidates.
• Optimize management of comorbidities included in MFI-5 prior to surgery.
• Provide tailored perioperative care and monitoring for patients identified as frail by MFI-5.
• Use MFI-5 to guide informed consent discussions regarding surgical risks.

References

• Frailty syndrome and its biological basis
• Development and validation of Modified Frailty Index-5
• Risks of antihypertensive medications in surgery
• Hypertension as a component of MFI-5
• Impact of diabetes mellitus on postoperative pulmonary complications
• COPD as a risk factor for postoperative complications in lung resections
• Congestive heart failure and postoperative morbidity
• CHF and hospital readmission after pulmonary resections
• Functional status and postoperative complications
• Clavien–Dindo classification of surgical complications
• Use of MFI-5 in thoracic surgery